(Q46908055)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24715154%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

title

Emergence of echinocandin-resistant Candida spp. in a hospital setting: a consequence of 10 years of increasing use of antifungal therapy? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24715154%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24715154%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Sébastien Imbert

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24715154%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

author name string

A Fekkar

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24715154%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

I Meyer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24715154%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

J Y Brossas

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24715154%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

M Uzunov

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24715154%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

G Mellon

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24715154%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

S Nguyen

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24715154%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

E Guiller

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24715154%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

E Caumes

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24715154%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

V Leblond

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24715154%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

D Mazier

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24715154%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

M H Fievet

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24715154%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

A Datry

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24715154%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

publication date

9 April 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24715154%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Clinical Microbiology & Infectious Diseases

13 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24715154%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24715154%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24715154%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

page(s)

1489-1496

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24715154%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10096-014-2096-9

13 March 2020

exact match

0 references

cites work

Impact of prior inappropriate fluconazole dosing on isolation of fluconazole-nonsusceptible Candida species in hospitalized patients with candidemia

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2096-9

Acquired bloodstream infection in the intensive care unit: incidence and attributable mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2096-9

Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2096-9

Candida spp. with acquired echinocandin resistance, France, 2004-2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2096-9

Breakthrough invasive candidiasis in patients on micafungin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2096-9

Characterisation of breakthrough invasive mycoses in echinocandin recipients: an evidence-based review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2096-9

Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2096-9

Low prevalence of fks1 hot spot 1 mutations in a worldwide collection of Candida strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2096-9

Clinically significant micafungin resistance in Candida albicans involves modification of a glucan synthase catalytic subunit GSC1 (FKS1) allele followed by loss of heterozygosity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2096-9

Rapid emergence of echinocandin resistance during Candida kefyr fungemia treatment with caspofungin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2096-9

Mutations in the fks1 gene in Candida albicans, C. tropicalis, and C. krusei correlate with elevated caspofungin MICs uncovered in AM3 medium using the method of the European Committee on Antibiotic Susceptibility Testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2096-9

FKS1 mutations responsible for selective resistance of Saccharomyces cerevisiae to the novel 1,3-beta-glucan synthase inhibitor arborcandin C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2096-9

Candida albicans and Candida glabrata clinical isolates exhibiting reduced echinocandin susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2096-9

Progressive loss of echinocandin activity following prolonged use for treatment of Candida albicans oesophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2096-9

The Saccharomyces cerevisiae FKS1 (ETG1) gene encodes an integral membrane protein which is a subunit of 1,3-beta-D-glucan synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2096-9

Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant bloodstream isolates of Candida glabrata

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2096-9

Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2096-9

Fitness and virulence costs of Candida albicans FKS1 hot spot mutations associated with echinocandin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2096-9

The relationship between antifungal usage and antifungal susceptibility in clinical isolates of Candida: a multicenter Korean study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2096-9

Association between incidence of candidaemia and consumption of antifungal agents at a medical centre in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2096-9

Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2096-9

ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2096-9

Practical considerations on current guidelines for the management of non-neutropenic adult patients with candidaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2096-9

A non-compulsory stewardship programme for the management of antifungals in a university-affiliated hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2096-9

A matched-control evaluation of an antifungal bundle in the intensive care unit at a university teaching hospital.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2096-9

Breakthrough invasive mould infections in patients treated with caspofungin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-014-2096-9

Characterization of echinocandin-resistant mutants of Candida albicans: genetic, biochemical, and virulence studies

21 January 2018

1 reference

12 December 2020

Candida species bloodstream infection: epidemiology and outcome in a single institution from 1991 to 2008

1 reference

12 December 2020

Economic analysis of inadequate fluconazole therapy in non-neutropenic patients with candidaemia: a multi-institutional study

1 reference

12 December 2020

Evaluation of antifungal therapy in patients with candidaemia based on susceptibility testing results: implications for antimicrobial stewardship programmes

1 reference

12 December 2020

10.1007/S10096-014-2096-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24715154%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

1 reference